{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:06:04Z","timestamp":1784898364658,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00702-012-0952-2","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T21:20:44Z","timestamp":1355865644000},"page":"1237-1246","source":"Crossref","is-referenced-by-count":40,"title":["Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions"],"prefix":"10.1007","volume":"120","author":[{"given":"S.","family":"Unterecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Proft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pfuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"952_CR1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/bmj.4.5686.764","volume":"4","author":"B Alexanderson","year":"1969","unstructured":"Alexanderson B, Evans DA, Sjoqvist F (1969) Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J 4:764\u2013768","journal-title":"Br Med J"},{"key":"952_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","volume":"20","author":"M Aravagiri","year":"1999","unstructured":"Aravagiri M, Teper Y, Marder SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20:369\u2013377","journal-title":"Biopharm Drug Dispos"},{"key":"952_CR3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2165\/00023210-199504060-00006","volume":"4","author":"EA Balant-Gorgia","year":"1995","unstructured":"Balant-Gorgia EA, Balant LP (1995) Therapeutic drug monitoring. Relevance during the drug treatment of psychiatric disorders. CNS Drugs 4:432\u2013453","journal-title":"CNS Drugs"},{"key":"952_CR4","first-page":"1","volume":"37","author":"P Baumann","year":"2004","unstructured":"Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, M\u00fcller-Oerlinghausen B, Rao ML, Riederer P, Zernig G (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:1\u201323","journal-title":"Pharmacopsychiatry"},{"key":"952_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007691-200404000-00010","volume":"26","author":"F Bengtsson","year":"2006","unstructured":"Bengtsson F (2006) Therapeutic drug monitoring of psychotropic drugs. TDM \u201cnouveau\u201d. Ther Drug Monit 26:145\u2013151","journal-title":"Ther Drug Monit"},{"key":"952_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0140-6736(81)92894-4","volume":"339","author":"L Bertilsson","year":"1981","unstructured":"Bertilsson L, Mellstr\u00f6m B, Sj\u00f6kvist F, Martenson B, Asberg M (1981) Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications. Lancet 339:560\u2013561","journal-title":"Lancet"},{"key":"952_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pds.1697","volume":"18","author":"SJ Billups","year":"2009","unstructured":"Billups SJ, Delate T, Dugan D (2009) Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations. Pharmacoepidemiol Drug Saf 18:253\u2013257","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"952_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0924-977X(01)00101-8","volume":"11","author":"K Br\u00f8sen","year":"2001","unstructured":"Br\u00f8sen K, Naranjo CA (2001) Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 11:275\u2013283","journal-title":"Eur Neuropsychopharmacol"},{"key":"952_CR9","doi-asserted-by":"crossref","unstructured":"Carrasco-Portugal M, Flores-Murrieta FJ (2011) Gender differences in the pharmacokinetics of oral drugs. Pharmacol Pharm 2:31\u201341","DOI":"10.4236\/pp.2011.21004"},{"key":"952_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00023210-200013050-00006","volume":"13","author":"J Donoghue","year":"2000","unstructured":"Donoghue J, Taylor DM (2000) Suboptimal use of antidepressants in the treatment of depression. CNS Drugs 13:365\u2013383","journal-title":"CNS Drugs"},{"key":"952_CR11","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1097\/00004714-199606002-00009","volume":"16","author":"L Ereshefsky","year":"1996","unstructured":"Ereshefsky L (1996) Drug\u2013drug interactions involving antidepressants: focus on venlafaxine. J Clin Psychopharmacol 16:37S\u201350S","journal-title":"J Clin Psychopharmacol"},{"key":"952_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00470582","volume":"78","author":"RK Glotzbach","year":"1982","unstructured":"Glotzbach RK, Preskorn SH (1982) Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology 78:25\u201327","journal-title":"Psychopharmacology"},{"key":"952_CR13","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.1365-2125.2001.00770.x","volume":"52","author":"AS Gross","year":"2001","unstructured":"Gross AS (2001) Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 52:5S\u201310S","journal-title":"Br J Clin Pharmacol"},{"key":"952_CR14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0031-1286282","volume":"44","author":"G Gr\u00fcnder","year":"2011","unstructured":"Gr\u00fcnder G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I (2011) Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging. Pharmacopsychiatry 44:236\u2013248","journal-title":"Pharmacopsychiatry"},{"key":"952_CR15","first-page":"21","volume":"2","author":"C Hiemke","year":"1995","unstructured":"Hiemke C (1995) Therapeutisches drug monitoring von antidepressiva und neuroleptika methodische voraussetzungen. Psychopharmakotherapie 2:21\u201323","journal-title":"Psychopharmakotherapie"},{"key":"952_CR16","first-page":"106","volume-title":"Laboruntersuchungen in der psychiatrischen Routine","author":"C Hiemke","year":"2000","unstructured":"Hiemke C, H\u00e4rtter S, Weigmann H (2000) Therapeutisches Drug Monitoring. In: Gastpar M, Manger M (eds) Laboruntersuchungen in der psychiatrischen Routine. Thieme, Stuttgart, pp 106\u2013133"},{"key":"952_CR17","first-page":"26","volume":"27","author":"C Hiemke","year":"2003","unstructured":"Hiemke C, Sachse J, K\u00f6ller J, Weigmann H, H\u00e4rtter S (2003) HPLC with column-switching for therapeutic monitoring of psychoactive drugs. Clin Lab 27:26\u201327","journal-title":"Clin Lab"},{"key":"952_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gr\u00fcnder G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, M\u00fcller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44:195\u2013235","journal-title":"Pharmacopsychiatry"},{"key":"952_CR19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v63n0913","volume":"63","author":"RM Hirschfeld","year":"2002","unstructured":"Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, Hawley C, Kasper S, Linden M, Massana J, Mendlewicz J, M\u00f6ller HJ, Nemeroff CB, Saiz J, Such P, Torta R, Versiani M (2002) Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry 63:826\u2013837","journal-title":"J Clin Psychiatry"},{"key":"952_CR20","first-page":"66","volume":"43","author":"LE Hollister","year":"1982","unstructured":"Hollister LE (1982) Serum concentrations of tricyclic antidepressants in clinical practice. J Clin Psychiatry 43:66\u201369","journal-title":"J Clin Psychiatry"},{"key":"952_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-2952(92)90010-G","volume":"44","author":"CM Hunt","year":"1992","unstructured":"Hunt CM, Westerkam WR, Stave GM (1992) Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 44:275\u2013283","journal-title":"Biochem Pharmacol"},{"key":"952_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0447.1989.tb07176.x","volume":"S350","author":"CM Kaye","year":"1989","unstructured":"Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TCG, Zussman BD, Greb WH (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand S350:60\u201375","journal-title":"Acta Psychiatr Scand"},{"key":"952_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67\u201376","journal-title":"Drug Metab Rev"},{"key":"952_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/089198879400700302","volume":"7","author":"ME Kunik","year":"1994","unstructured":"Kunik ME, Pollock BG, Perel JM, Altieri L (1994) Clomipramine in the elderly: tolerance and plasma levels. J Geriatr Psychiatry Neurol 7:139\u2013143","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"952_CR25","volume-title":"Plasmaspiegelbestimmung von Psychopharmaka: Therapeutisches Drug Monitoring","author":"G Laux","year":"1992","unstructured":"Laux G, Riederer P (1992) Plasmaspiegelbestimmung von Psychopharmaka: Therapeutisches Drug Monitoring. Wissenschaftliche Verlagsgesellschaft, Stuttgart"},{"key":"952_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00007691-199604000-00001","volume":"18","author":"E Leinonen","year":"1996","unstructured":"Leinonen E, Lepola U, Koponen H, Kinnunen I (1996) The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenantioselective method. Ther Drug Monit 18:111\u2013117","journal-title":"Ther Drug Monit"},{"key":"952_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0447.1989.tb07177.x","volume":"80","author":"J Lundmark","year":"1989","unstructured":"Lundmark J, Scheel Thomsen I, Fjord-Larsen T, Manniche PM, Mengel H, Moller-Nielsen EM, Pauser H, Walinder J (1989) Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta Psychiatr Scand 80:76\u201380","journal-title":"Acta Psychiatr Scand"},{"key":"952_CR28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007691-200008000-00014","volume":"22","author":"J Lundmark","year":"2000","unstructured":"Lundmark J, Reis M, Bengtsson F (2000) Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting. Ther Drug Monit 22:446\u2013454","journal-title":"Ther Drug Monit"},{"key":"952_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.ftd.0000189897.16307.65","volume":"28","author":"K Mann","year":"2006","unstructured":"Mann K, Hiemke C, Schmidt LG, Bates DW (2006) Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care. Ther Drug Monit 28:83\u201388","journal-title":"Ther Drug Monit"},{"key":"952_CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00228-002-0448-3","volume":"58","author":"M Meyer-Barner","year":"2002","unstructured":"Meyer-Barner M, Meineke I, Schreeb KH, Gleiter CH (2002) Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approach. Eur J Clin Pharmacol 58:253\u2013257","journal-title":"Eur J Clin Pharmacol"},{"key":"952_CR31","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1046\/j.1365-2125.2001.00174.x","volume":"52","author":"PB Mitchell","year":"2001","unstructured":"Mitchell PB (2001) Therapeutic drug monitoring of psychotropic medications. Br J Clin Pharmacol 52:45S\u201354S","journal-title":"Br J Clin Pharmacol"},{"key":"952_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-2003-39983","volume":"36","author":"M M\u00fcller","year":"2003","unstructured":"M\u00fcller M, Dragicevic A, Fric M, Gaertner I, Grasmader K, Hartter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C (2003) Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Pharmacopsychiatry 36:98\u2013104","journal-title":"Pharmacopsychiatry"},{"key":"952_CR33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-211-73574-9_35","volume":"72","author":"B Pfuhlmann","year":"2007","unstructured":"Pfuhlmann B, Gerlach M, Burger R, Gonska S, Unterecker S, Jabs B, Riederer P, Deckert J (2007) Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice. J Neural Transm Suppl 72:287\u2013296","journal-title":"J Neural Transm Suppl"},{"key":"952_CR34","first-page":"23","volume":"52S","author":"SH Preskorn","year":"1991","unstructured":"Preskorn SH, Fast GA (1991) Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry 52S:23\u201333","journal-title":"J Clin Psychiatry"},{"key":"952_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/JCP.0b013e318192e4c1","volume":"29","author":"S Preskorn","year":"2009","unstructured":"Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, Ahmed S, Paul J, Nichols AI (2009) Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. J Clin Psychopharmacol 29:39\u201343","journal-title":"J Clin Psychopharmacol"},{"key":"952_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-979552","volume":"29","author":"ML Rao","year":"1996","unstructured":"Rao ML, Deister A, Laux G, Staberock U, H\u00f6flich G, M\u00f6ller HJ (1996) Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse. Pharmacopsychiatry 29:97\u2013102","journal-title":"Pharmacopsychiatry"},{"key":"952_CR37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","volume":"19","author":"M Reis","year":"2004","unstructured":"Reis M, Aberg-Wistedt A, Agren H, H\u00f6glund P, Akerblad A, Bengtsson F (2004) Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6\u00a0months of treatment for major depression. Hum Psychopharmacol 19:283\u2013291","journal-title":"Hum Psychopharmacol"},{"key":"952_CR38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/FTD.0b013e31815b3f62","volume":"29","author":"M Reis","year":"2007","unstructured":"Reis M, Cherma MD, Carlsson B, Bengtsson F (2007) Therapeutic drug monitoring of escitalopram in an outpatient setting. Ther Drug Monit 29:758\u2013766","journal-title":"Ther Drug Monit"},{"key":"952_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","volume":"31","author":"M Reis","year":"2009","unstructured":"Reis M, Aamo T, Spigset O, Ahlner J (2009) Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 31:42\u201356","journal-title":"Ther Drug Monit"},{"key":"952_CR40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4065\/72.9.835","volume":"72","author":"E Richelson","year":"1997","unstructured":"Richelson E (1997) Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 72:835\u2013847","journal-title":"Mayo Clin Proc"},{"issue":"S1","key":"952_CR41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199700321-00004","volume":"32","author":"RA Ronfeld","year":"1997","unstructured":"Ronfeld RA, Tremaine LM, Wilner KD (1997) Pharmacokinetics of sertraline and its N-dimethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 32(S1):22\u201330","journal-title":"Clin Pharmacokinet"},{"key":"952_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.clpt.6100226","volume":"82","author":"JB Schwartz","year":"2007","unstructured":"Schwartz JB (2007) The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 82:87\u201396","journal-title":"Clin Pharmacol Ther"},{"key":"952_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR (2009) Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 48:143\u2013157","journal-title":"Clin Pharmacokinet"},{"key":"952_CR44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-199427030-00001","volume":"27","author":"AL Tonkin","year":"1994","unstructured":"Tonkin AL, Bochner F (1994) Therapeutic drug monitoring and patient outcome. Clin Pharmacokinet 27:169\u2013174","journal-title":"Clin Pharmacokinet"},{"key":"952_CR45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/00003088-200241110-00004","volume":"41","author":"S Ulrich","year":"2002","unstructured":"Ulrich S, L\u00e4uter J (2002) A comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clin Pharmacokin 41:853\u2013876","journal-title":"Clin Pharmacokin"},{"key":"952_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2001-15207","volume":"34","author":"S Ulrich","year":"2001","unstructured":"Ulrich S, Northoff G, Wurthmann C, Partscht G, Pester U, Herscu H, Meyer FP (2001) Serum levels of amitriptyline and therapeutic effect in moderate to severely, non-delusional depressed inpatients: a therapeutic window relationship. Pharmacopsychiatry 34:33\u201340","journal-title":"Pharmacopsychiatry"},{"key":"952_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0032-1326769","volume":"45","author":"S Unterecker","year":"2012","unstructured":"Unterecker S, Hiemke C, Greiner C, Haen E, Jabs B, Deckert J, Pfuhlmann B (2012) The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethyl-venlafaxine under naturalistic conditions. Pharmacopsychiatry 45:229\u2013235","journal-title":"Pharmacopsychiatry"},{"key":"952_CR48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00007691-200004000-00011","volume":"22","author":"AH Veefkind","year":"2000","unstructured":"Veefkind AH, Haffmans PM, Hoencamp E (2000) Venlafaxine serum levels and CYP2D6 genotype. Ther Drug Monit 22:202\u2013208","journal-title":"Ther Drug Monit"},{"key":"952_CR49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2007-1014468","volume":"24","author":"F Vuille","year":"1991","unstructured":"Vuille F, Amey M, Baumann P (1991) Use of serum level monitoring of antidepressants in clinical practice. Pharmacopsychiatry 24:190\u2013195","journal-title":"Pharmacopsychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0952-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0952-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0952-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:30:22Z","timestamp":1559089822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0952-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0952-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}